eBook:
The lack of diversity in clinical trials is one of the biggest obstacles to achieving true health equity. Despite making up a significant portion of the U.S. population, communities of color have historically been underrepresented in clinical research.
This lack of representation means treatments are not adequately tested on diverse populations, leading to skewed data, unfavorable health outcomes, rising healthcare costs, and a perpetuation of existing health inequalities.
The FDA has taken note, issuing new draft guidance that recommends pharmaceutical companies submit race and ethnicity diversity action plans for clinical trials—or risk delays. Building a robust strategy to improve diversity is now a necessity, as well as an ethical imperative.
Download this in-depth guide to gain a comprehensive understanding of clinical trial diversity challenges and solutions to drive health equity.
What's Inside:
Our guide explores strategies to enhance diversity and inclusivity in clinical research.
You'll learn:
The profound impacts of diversity in clinical trials on health equity
How to build affective trust with communities of color to increase participation
Strategies for developing a robust FDA-compliant diversity action plan
The role of innovative technology in enabling diversity outreach
Examine the current state of diversity in clinical trials, why inclusivity is so vital, and the stark consequences of underrepresented populations.
A revealing look at the financial impacts and human costs of non-diverse clinical trial research.
Understand the deep-rooted mistrust of the medical system by communities of color due to a long history of exploitation. Learn practical strategies for building affective trust to overcome recruitment challenges.
We break down the latest FDA guidance, including recommendations on data collection, reporting, and more. You'll also learn how technology can support clinical trial diversity goals.
© 2024 Acclinate. All rights reserved. Privacy Policy
